{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Rationale&page=2", "query": { "intervention": "Standard Rationale", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Rationale&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-15T14:42:23.863Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06494579", "title": "Lamivudine for Solid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Relapsed/Refractory Solid Tumors" ], "interventions": [ { "name": "Lamivudine", "type": "DRUG" }, { "name": "PD-L1 Blocker", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Thomas Marron", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2024-09-26", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06494579" }, { "nct_id": "NCT05277831", "title": "Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation", "Smoking", "Smoking Reduction", "Smoking, Cigarette", "Smoking (Tobacco) Addiction", "Smoking Habit" ], "interventions": [ { "name": "Guided Imagery Intervention", "type": "OTHER" }, { "name": "Standard Behavioral Control", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1209, "start_date": "2022-08-01", "completion_date": "2025-10-26", "has_results": false, "last_update_posted_date": "2025-11-24", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05277831" }, { "nct_id": "NCT01871766", "title": "Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rhabdomyosarcoma" ], "interventions": [ { "name": "Vincristine", "type": "DRUG" }, { "name": "Dactinomycin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Surgical Resection", "type": "PROCEDURE" }, { "name": "Radiation", "type": "PROCEDURE" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" }, { "name": "Myeloid Growth Factor", "type": "DRUG" }, { "name": "Lymph Node Sampling", "type": "PROCEDURE" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Etoposide Phosphate", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Dexrazoxane", "type": "DRUG" }, { "name": "^1^1C-methionine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 115, "start_date": "2013-12-04", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 4, "location_summary": "Jacksonville, Florida • Memphis, Tennessee • Fort Worth, Texas", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01871766" }, { "nct_id": "NCT00826800", "title": "Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colon Cancer" ], "interventions": [ { "name": "FOLFOX and bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 2, "start_date": "2009-02", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2015-04-15", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 5, "location_summary": "Basking Ridge, New Jersey • Commack, New York • New York, New York + 2 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Rockville Centre", "state": "New York" }, { "city": "Sleepy Hollow", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00826800" }, { "nct_id": "NCT05439772", "title": "Examining the Effect of Ondansetron on Bowel Prep Success", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Abdominal Pain", "Inflammatory Bowel Diseases", "Eosinophilic Gastroenteritis", "Diarrhea", "Hematochezia", "Weight Loss" ], "interventions": [ { "name": "Ondansetron", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "State University of New York - Downstate Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "2 Years to 20 Years" }, "enrollment_count": 41, "start_date": "2021-01-01", "completion_date": "2023-07-01", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "Brooklyn, New York", "locations": [ { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05439772" }, { "nct_id": "NCT05775133", "title": "Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic Cholecystectomy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cholecystitis", "Cholelithiasis", "Biliary Dyskinesia" ], "interventions": [ { "name": "ICG", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Activ Surgical", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2023-08-01", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2024-02-21", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05775133" }, { "nct_id": "NCT02139072", "title": "CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Antiphospholipid Antibody Syndrome" ], "interventions": [ { "name": "CoaguChek XS", "type": "DEVICE" }, { "name": "Standard Lab Draw", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2015-03", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2016-10-04", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02139072" }, { "nct_id": "NCT03219177", "title": "Patient Education and Use of Post Operative Pain Medication in Ambulatory Hand Surgery: a Randomized Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ambulatory Hand Surgery" ], "interventions": [ { "name": "Patient education regarding indications for opioid use and side effects of opioid use after hand surgery", "type": "BEHAVIORAL" }, { "name": "Standard of care post-operative counseling", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 400, "start_date": "2017-06-15", "completion_date": "2022-12-06", "has_results": false, "last_update_posted_date": "2022-12-16", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03219177" }, { "nct_id": "NCT07458230", "title": "Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation:", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Next Generation Sequencing (NGS)", "Surgical Site Infection (SSI)", "Fracture Fixation" ], "interventions": [ { "name": "NGS diagnostic findings", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 250, "start_date": "2026-10-01", "completion_date": "2028-10-01", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 18, "location_summary": "Tuscaloosa, Alabama • Los Angeles, California • San Francisco, California + 15 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Maywood", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07458230" }, { "nct_id": "NCT07139990", "title": "Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Small Cell Lung Cancer Extensive Stage", "Brain Metastases", "Solid Tumor, Adult", "Thoracic Cancer", "Sarcoma,Soft Tissue", "HNPCC" ], "interventions": [ { "name": "Cohort A: Extensive Stage Small Cell Lung Cancer (ES-SCLC) Thoracic Tumor PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy)", "type": "RADIATION" }, { "name": "Cohort B: Brain metastasis PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy)", "type": "RADIATION" }, { "name": "Cohort C: Sarcoma Pre-Operative PULSAR", "type": "RADIATION" }, { "name": "Cohort D: Resectable Head & Neck Squamous Cell Carcinoma (HNSCC) PULSAR/SAbR", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2025-10-28", "completion_date": "2032-09-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-15T14:42:23.863Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07139990" } ] }